Literature DB >> 19487567

Transcription termination by nuclear RNA polymerases.

Patricia Richard1, James L Manley.   

Abstract

Gene transcription in the cell nucleus is a complex and highly regulated process. Transcription in eukaryotes requires three distinct RNA polymerases, each of which employs its own mechanisms for initiation, elongation, and termination. Termination mechanisms vary considerably, ranging from relatively simple to exceptionally complex. In this review, we describe the present state of knowledge on how each of the three RNA polymerases terminates and how mechanisms are conserved, or vary, from yeast to human.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19487567      PMCID: PMC2763537          DOI: 10.1101/gad.1792809

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  287 in total

1.  Derailing the locomotive: transcription termination.

Authors:  David S Gilmour; Ruopeng Fan
Journal:  J Biol Chem       Date:  2007-11-12       Impact factor: 5.157

Review 2.  The expanding RNA polymerase III transcriptome.

Authors:  Giorgio Dieci; Gloria Fiorino; Manuele Castelnuovo; Martin Teichmann; Aldo Pagano
Journal:  Trends Genet       Date:  2007-10-30       Impact factor: 11.639

3.  RNA polymerase II pauses and associates with pre-mRNA processing factors at both ends of genes.

Authors:  Kira Glover-Cutter; Soojin Kim; Joaquin Espinosa; David L Bentley
Journal:  Nat Struct Mol Biol       Date:  2007-12-23       Impact factor: 15.369

4.  Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7.

Authors:  Rob D Chapman; Martin Heidemann; Thomas K Albert; Reinhard Mailhammer; Andrew Flatley; Michael Meisterernst; Elisabeth Kremmer; Dirk Eick
Journal:  Science       Date:  2007-12-14       Impact factor: 47.728

Review 5.  Human RNA polymerase II-associated factor complex: dysregulation in cancer.

Authors:  K Chaudhary; S Deb; N Moniaux; M P Ponnusamy; S K Batra
Journal:  Oncogene       Date:  2007-06-18       Impact factor: 9.867

6.  Polyadenylation site choice in yeast is affected by competition between Npl3 and polyadenylation factor CFI.

Authors:  Miriam E Bucheli; Xiaoyuan He; Craig D Kaplan; Claire L Moore; Stephen Buratowski
Journal:  RNA       Date:  2007-08-07       Impact factor: 4.942

Review 7.  Overlapping pathways dictate termination of RNA polymerase II transcription.

Authors:  Søren Lykke-Andersen; Torben Heick Jensen
Journal:  Biochimie       Date:  2007-06-02       Impact factor: 4.079

8.  Serine-7 of the RNA polymerase II CTD is specifically required for snRNA gene expression.

Authors:  Sylvain Egloff; Dawn O'Reilly; Rob D Chapman; Alice Taylor; Katrin Tanzhaus; Laura Pitts; Dirk Eick; Shona Murphy
Journal:  Science       Date:  2007-12-14       Impact factor: 47.728

9.  Different domains of the murine RNA polymerase I-specific termination factor mTTF-I serve distinct functions in transcription termination.

Authors:  R Evers; A Smid; U Rudloff; F Lottspeich; I Grummt
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

10.  Trf4 targets ncRNAs from telomeric and rDNA spacer regions and functions in rDNA copy number control.

Authors:  Jonathan Houseley; Kimberly Kotovic; Aziz El Hage; David Tollervey
Journal:  EMBO J       Date:  2007-11-15       Impact factor: 11.598

View more
  169 in total

1.  Ssu72 phosphatase-dependent erasure of phospho-Ser7 marks on the RNA polymerase II C-terminal domain is essential for viability and transcription termination.

Authors:  David W Zhang; Amber L Mosley; Sreenivasa R Ramisetty; Juan B Rodríguez-Molina; Michael P Washburn; Aseem Z Ansari
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

2.  Prolonged α-amanitin treatment of cells for studying mutated polymerases causes degradation of DSIF160 and other proteins.

Authors:  David C Tsao; Noh Jin Park; Anita Nag; Harold G Martinson
Journal:  RNA       Date:  2011-12-22       Impact factor: 4.942

3.  Transcriptional activators enhance polyadenylation of mRNA precursors.

Authors:  Takashi Nagaike; James L Manley
Journal:  RNA Biol       Date:  2011-11-01       Impact factor: 4.652

4.  A dominant role for meiosis-specific 3' RNA processing in controlling expression of a fission yeast cyclin gene.

Authors:  Kristine Potter; Nicole Cremona; Sham Sunder; Jo Ann Wise
Journal:  RNA       Date:  2012-05-30       Impact factor: 4.942

5.  Coupled RNA polymerase II transcription and 3' end formation with yeast whole-cell extracts.

Authors:  Luisa Mariconti; Bernhard Loll; Karola Schlinkmann; Agnieszka Wengi; Anton Meinhart; Bernhard Dichtl
Journal:  RNA       Date:  2010-09-01       Impact factor: 4.942

6.  Effects of Transcription Elongation Rate and Xrn2 Exonuclease Activity on RNA Polymerase II Termination Suggest Widespread Kinetic Competition.

Authors:  Nova Fong; Kristopher Brannan; Benjamin Erickson; Hyunmin Kim; Michael A Cortazar; Ryan M Sheridan; Tram Nguyen; Shai Karp; David L Bentley
Journal:  Mol Cell       Date:  2015-10-15       Impact factor: 17.970

7.  Coordination of RNA Polymerase II Pausing and 3' End Processing Factor Recruitment with Alternative Polyadenylation.

Authors:  Becky Fusby; Soojin Kim; Benjamin Erickson; Hyunmin Kim; Martha L Peterson; David L Bentley
Journal:  Mol Cell Biol       Date:  2015-11-02       Impact factor: 4.272

8.  A high density of cis-information terminates RNA Polymerase III on a 2-rail track.

Authors:  Aneeshkumar G Arimbasseri; Richard J Maraia
Journal:  RNA Biol       Date:  2015-12-04       Impact factor: 4.652

Review 9.  Transcription termination by the eukaryotic RNA polymerase III.

Authors:  Aneeshkumar G Arimbasseri; Keshab Rijal; Richard J Maraia
Journal:  Biochim Biophys Acta       Date:  2012-10-23

10.  RHON1 mediates a Rho-like activity for transcription termination in plastids of Arabidopsis thaliana.

Authors:  Wei Chi; Baoye He; Nikolay Manavski; Juan Mao; Daili Ji; Congming Lu; Jean David Rochaix; Jörg Meurer; Lixin Zhang
Journal:  Plant Cell       Date:  2014-12-05       Impact factor: 11.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.